Pfizer, BioNTech begin coronavirus vaccine trial in humans

Pfizer Inc. and BioNTech have announced the start of coronavirus vaccine trials in human patients. In anticipation of success, production has been scaled for a global supply meaning millions of vaccines could be available this year.